Inhibitory Effects of 4-n-Butylresorcinol on Tyrosinase Activity and Melanin Synthesis
Authors:
Open Access
- 1 January 2005
- journal article
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 28 (12) , 2216-2219
Abstract
In this study, we investigated the effects of 4-n-butylresorcinol on melanogenesis in a spontaneously immortalized mouse melanocyte cell line, Mel-Ab. Our results show that 4-n-butylresorcinol significantly inhibits melanin synthesis in a concentration-dependent manner. In addition, it was also found to inhibit the activity of tyrosinase, the rate-limiting melanogenic enzyme. Several reports have indicated that the activation of extracellular signal-regulated kinase (ERK) or of Akt reduces melanin synthesis via microphthalmia-associated transcription factor (MITF) down-regulation. Accordingly, we examined the effects of 4-n-butylresorcinol on the ERK and Akt signaling pathways. 4-n-Butylresorcinol did not induce ERK, Akt activation, or MITF degradation, and had no effect on cAMP response element binding protein (CREB) phosphorylation, which stimulates MITF expression. In contrast, 4-n-butylresorcinol strongly reduced tyrosinase activity in a cell-free system. Moreover, 4-n-butylresorcinol showed an additive effect in combination with hinokitiol, which reduces MITF expression. These results show that the hypopigmentary effect of 4-n-butylresorcinol results from its direct inhibition of tyrosinase.Keywords
This publication has 28 references indexed in Scilit:
- Glycogen Synthase Kinase 3β Is Activated by cAMP and Plays an Active Role in the Regulation of MelanogenesisJournal of Biological Chemistry, 2002
- Regulation of Microphthalmia-Associated Transcription Factor MITF Protein Levels by Association with the Ubiquitin-Conjugating Enzyme hUBC9Experimental Cell Research, 2000
- Inhibition of Tyrosinase by Flavonoids, Stilbenes and Related 4-Substituted Resorcinols: Structure-Activity InvestigationsPlanta Medica, 2000
- Inhibition of the Mitogen-activated Protein Kinase Pathway Triggers B16 Melanoma Cell DifferentiationJournal of Biological Chemistry, 1998
- Evidence to Suggest That Expression of MITF Induces Melanocyte Differentiation and Haploinsufficiency of MITF Causes Waardenburg Syndrome Type 2APigment Cell Research, 1997
- Functional Analysis of Microphthalmia-associated Transcription Factor in Pigment Cell-specific Transcription of the Human Tyrosinase Family GenesJournal of Biological Chemistry, 1997
- Inhibition of the Phosphatidylinositol 3-Kinase/p70S6-Kinase Pathway Induces B16 Melanoma Cell DifferentiationJournal of Biological Chemistry, 1996
- Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) geneNature Genetics, 1994
- A gene for Waardenburg Syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12–p14.1Nature Genetics, 1994
- Analysis of Mammalian Pigmentation at the Molecular LevelPigment Cell Research, 1989